Transforming growth factor-β isoform expression in human ovarian tumours

European Journal of Cancer

Volumn 33, Issue 14, 1997, Pages 2397-2403

  Bartlett, J M ^a   Langdon, S P ^a   Scott, W N ^a   Love, S B ^b   Miller, E P ^a   Katsaros, D ^c   Smyth, J F ^a   Miller, W R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Cancer; Ovarian; Progression; Survival; TGF

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

DISEASE PROGRESSION; FEMALE; HUMANS; OVARIAN NEOPLASMS; PLOIDIES; RECEPTORS, PROGESTERONE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA PROBES; RNA, MESSENGER; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031415228     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00304-3     Document Type: Article

References (30)

1. Roberts AB, Sporn MB. The transforming growth factor-betas. In Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors, Heidelberg, Springer, 1990, 419-472.
2. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
3. Massague J. Receptors for the TGF-β family. Cell. 69:1992;1067-1070.
4. Bartlett JM, Rabiasz GJ, Scott WN, Langdon SP, Smyth JF, Miller WR. Transforming growth factor-β mRNA expression in growth control of human ovarian carcinoma cells. Br J Cancer. 65:1992;655-660.
5. Berchuck A, Olt GJ, Everitt L, Soisson AP, Bast RC, Boyer CM. The role of peptide growth factors in epithelial ovarian cancer. Obstet Gynecol. 75:1990;255-262.
6. Berchuck A, Rodriguez GC, Olt GJ, et al. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am J Obstet Gynecol 1992, 166, 676-684.
7. Marth C, Lang T, Koza A, Mayer I, Daxenblicher G. Transforming growth factor-β and ovarian carcinoma cells: regulation of proliferation and surface antigen expression. Cancer Lett. 51:1990;221-225.
8. Jozan S, Guerrin M, Mazars P, et al. Transforming growth factor β1 (TGF-β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors. Int J Cancer 1992, 52, 766-770.
9. Zhou LI, Leung BS. Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factor-α and β1. Biochem Biophys Acta. 1080:1992;130-136.
10. Skinner MK, Keski-Oja J, Oskeen JG, Moses HL. Ovarian thecal cells produce transforming growth factor β which can regulate granulosa cell growth. Endocrinology. 121:1987;786-792.
11. Hurteau JA, Rodriguez GC, Whitaker RS, et al. Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 1994, 74, 93-99.
12. Havrilesky LJ, Hurteau A, Whitaker RS, et al. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor β1. Cancer Res 1995, 55, 944-948.
13. Serov SF, Scully RE. Histological typing of ovarian tumors. In International Histological Classification of Tumors, No. 9, Geneva, Switzerland, World Health Organisation, 1973.
14. International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987, 156, 263.
15. MacCallum J, Bartlett JMS, Thompson AM, Keen JC, Dixon JM, Miller WR. Expression of transforming growth factor-beta mRNA isoforms in human breast cancer. Br J Cancer. 69:1994;1006-1009.
16. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem. 72:1976;248-252.
17. Cox DR. Regression models and life tables. J Roy Stat Soc B. 34:1972;187-220.
18. Massague J, Polyak K. Mammalian antiproliferative signals and their targets. Curr Opin Genet Dev. 5:1995;91.
19. Selvakumuran M, Lin HK, Miyashita T, et al. Immediate early up-regulation of bax expression by p53 but not TGF-beta-1: a paradigm for distinct apoptotic pathways. Oncogene 1994, 9, 1791-1798.
20. Takahashi T, Eitzman B, Bossert NL, et al. Transforming growth factors β-1, β-2 and β-3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth - a comparison to other growth regulated genes. Cell Growth Differ 1994, 5, 919-935.
21. Jeng MH, Ten Dijke P, Iwata KK, Jordan VC. Regulation of the levels of three transforming growth factor beta mRNAs by estrogen and their effects on the proliferation of human breast cancer cells. Mol Cell Endocrinol. 97:1993;115-123.
22. Jordan VC. Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat. 31:1994;41-52.
23. Murphy LC, Alkhalaf M, Dotzlaw H, Coutts A, Haddadalkhalaf B. Regulation of gene expression in T-47D human breast cancer cells by progestins and anti-progestins. Human Reprod. 9:1994;174-180.
24. Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res. 52:1992;6949-6952.
25. Arteaga CL, Carty DT, Moses HL, Hurd SD, Pietenpol JA. Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ. 4:1993;193-201.
26. Li X, Nagayasu H, Hamada JI, Hosokawa M, Takeichi N. Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta. Jpn J Cancer Res. 84:1993;1145-1149.
27. MacCallum J, Poulsom R, Hanhy AM, Miller WR. Expression and distribution of TGF-β mRNA isoforms in a small group of human breast cancers examined by in situ hybridization. Breast. 4:1995;289-296.
28. Massague J. The transforming growth factor-beta family. Ann Rev Cell Biol. 6:1990;597-641.
29. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 108:1995;985-1002.
30. Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, Derynck R. Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2. Mol Endocrinol. 3:1989;1977-1986.